Found: 41
Select item for more details and to access through your institution.
The Association Between Obesity and Polycystic Ovary Syndrome: An Epidemiologic Study of Observational Data.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 10, p. 2640, doi. 10.1210/clinem/dgae488
- By:
- Publication type:
- Article
Response to Letter to the Editor From de Zegher and Ibáñez: "Adipose Tissue Dysfunction in Polycystic Ovary Syndrome".
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 10, p. e1973, doi. 10.1210/clinem/dgae407
- By:
- Publication type:
- Article
Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1112, doi. 10.1111/dom.14936
- By:
- Publication type:
- Article
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 812, doi. 10.1111/dom.13584
- By:
- Publication type:
- Article
Use of a metabolomic approach to non‐invasively diagnose non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1702, doi. 10.1111/dom.13285
- By:
- Publication type:
- Article
283-OR: Inadequate Hepatic Mitochondrial Adaptation in Patients with NASH Is Related to the Severity of Steatohepatitis and Fibrosis Stage.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-283-OR
- By:
- Publication type:
- Article
203-OR: Measurement of Intact Insulin by Mass Spectrometry Identifies Nonalcoholic Fatty Liver Disease (NAFLD).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-203-OR
- By:
- Publication type:
- Article
1463-P: Relationship between Hepatic and Adipose Tissue Insulin Resistance with Liver Fibrosis in Patients with Type 2 Diabetes Mellitus (T2DM) and Nonalcoholic Fatty Liver Disease (NAFLD).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1463-P
- By:
- Publication type:
- Article
1461-P: Liver Fibrosis Is Common in Patients with Type 2 Diabetes Mellitus (T2DM) and Nonalcoholic Fatty Liver Disease (NAFLD).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1461-P
- By:
- Publication type:
- Article
223-OR: Pioglitazone Discontinuation in Patients with Nonalcoholic Steatohepatitis (NASH) Is Associated with Disease Recurrence.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-223-OR
- By:
- Publication type:
- Article
PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH.
- Published in:
- Liver International, 2021, v. 41, n. 11, p. 2659, doi. 10.1111/liv.15005
- By:
- Publication type:
- Article
Nonalcoholic Fatty Liver Disease: Current Issues and Novel Treatment Approaches.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 1, p. 10, doi. 10.1210/clinem/dgad356
- By:
- Publication type:
- Article
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 5, p. 1192, doi. 10.1210/clinem/dgac660
- By:
- Publication type:
- Article
Differences in HDL-Bound Apolipoproteins in Patients With Advanced Liver Fibrosis Due to Nonalcoholic Fatty Liver Disease.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 1, p. 42, doi. 10.1210/clinem/dgac565
- By:
- Publication type:
- Article
Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
- Published in:
- PLoS ONE, 2021, v. 16, n. 6, p. 1, doi. 10.1371/journal.pone.0251449
- By:
- Publication type:
- Article
Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
- Published in:
- 2016
- By:
- Publication type:
- journal article
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
- Published in:
- 2015
- By:
- Publication type:
- journal article
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Noninvasive tests to identify liver fibrosis in metabolic dysfunction‐associated steatotic liver disease are affected by race.
- Published in:
- Obesity (19307381), 2024, v. 32, n. 3, p. 612, doi. 10.1002/oby.23960
- By:
- Publication type:
- Article
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Response to do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent?
- Published in:
- Liver International, 2015, v. 35, n. 10, p. 2341, doi. 10.1111/liv.12869
- By:
- Publication type:
- Article
Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients.
- Published in:
- Liver International, 2015, v. 35, n. 9, p. 2139, doi. 10.1111/liv.12840
- By:
- Publication type:
- Article
Noninvasive Diagnosis of Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis Using Machine Learning Methods: Comparative Study With Existing Quantitative Risk Scores.
- Published in:
- JMIR Medical Informatics, 2022, v. 10, n. 6, p. 1, doi. 10.2196/36997
- By:
- Publication type:
- Article
Endpoints in NASH Clinical Trials: Are We Blind in One Eye?
- Published in:
- Metabolites (2218-1989), 2024, v. 14, n. 1, p. 40, doi. 10.3390/metabo14010040
- By:
- Publication type:
- Article
A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.00752
- By:
- Publication type:
- Article
Re: "Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis" by Mantovani et al. (Thyroid 2018;28:1270–1284).
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36‐month clinical trial.
- Published in:
- Journal of Diabetes, 2019, v. 11, n. 3, p. 223, doi. 10.1111/1753-0407.12833
- By:
- Publication type:
- Article
Letter to the Editor: "Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content".
- Published in:
- 2019
- By:
- Publication type:
- journal article
Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187-192.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article